China approves first mixed-vaccine trial as Delta spreads

BEIJING, China (AFP) — China’s drug regulator has approved the country’s first mixed-vaccine trial, a company involved in the study said, as the rapid spread of the Delta variant raises concern about the efficacy of domestically produced jabs. The trial will test the efficacy of combining an “inactivated” vaccine made by China’s Sinovac with a DNA-based one developed by US pharmaceutical company Inovio, a statement issued on Tuesday said. The statement was put out by […]